ASP Isotopes (ASPI) stock price, chart and financials

Price chart

Revenue (trailing twelve months)

$30.9M

Revenue (quarter)

$5.1M

Revenue growth (year over year)

+327.63%

Gross profit (trailing twelve months)

$5.7M

Gross margin

18.32%

Net income (trailing twelve months)

−$117.3M

Net income (quarter)

−$34.0M

Net income growth (year over year)

+54.77%

Net margin

−380.33%

Return on equity

−91.09%

EPS (trailing twelve months)

−$1.27

Book value per share

$2.03

P/E (trailing twelve months)

—

Price to book

1.27

Debt to assets

51.96%

Payout ratio

—

Dividend yield

—

Company profile

ASP Isotopes Inc is a materials company focused on producing and commercializing enriched isotopes for the nuclear medicine, healthcare, green energy, and quantum computing industries. Currently, the company has three operating segments: (i) nuclear fuels, (ii) specialist isotopes and related services, and (iii) construction services. Using proprietary technology-the Aerodynamic Separation Process (ASP)-the company enriches isotopes in South Africa, targeting high-value, low-volume markets to reduce reliance on foreign supply chains. Geographically, the company operates in South Africa, Hong Kong and United States generating key revenue from the Hong Kong region.

• Is ASP Isotopes (ASPI) profitable?

  No. ASP Isotopes reported a net loss of $117.3M over the trailing twelve months.

• How much revenue does ASP Isotopes (ASPI) make?

  ASP Isotopes generated $30.9M in revenue over the trailing twelve months, up 327.63% year over year.

• How do I buy stock in ASP Isotopes (ASPI)?

  ASPI trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at Light Horse Dashboard, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.